Industry Watch｜Institute for Biotechnology and Medicine Industry│IBMI

Subject
Top 20 biomedical companies by revenue 2023
Taiwan business watch 2023: Biomedical sector by revenue
Taiwan biomedical sector by revenue 2013-2023
A few years after launch, Taiwan’s homegrown drugs striving for global expansion
Net income of biomedical companies dwindled: H1, 2023
Top 20 biomedical companies by EPS: H1, 2023
Taiwan business watch H1, 2023: Biomedical sector by revenue
Salary 2022: Non-managerial employees in Taiwan’s biomedical sector
Taiwan business watch Q1, 2023: Biomedical sector
Taiwan business watch 2022: Biomedical company profitability
Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment
Taiwan Business Watch H1, 2022: Biomedical Sector
Salary 2021: Non-Managerial Employees in Taiwan’s Biomedical Sector
Taiwan business watch Q1, 2022: Biomedical sector
Taiwan business watch 2021: Biomedical company profitability
Covid-19: FDA authorised and approved drugs and non-vaccine biological products
Taiwan business watch 2021: Biomedical top 20
Taiwan business watch 2021: Biomedical IPOs fueled by 24 new comers
Taiwan business watch Q1 to Q3, 2021: Biomedical sector
Covid-19 New Drugs Race: Overview of Global R&D Progress
Taiwan-Developed Drugs in Global Markets
Taiwan business watch H1, 2021: top performing biomedical companies
Taiwan business watch H1, 2021: Biomedical sector
Race for COVID-19 Vaccine: Global Rollout and Production by Country
Industry salary 2020: Biopharmaceutical non-managerial employees
Taiwan business Watch 2020: Biomedical Photonics
Taiwan business watch Q1, 2021: Biomedical sector
Taiwan business watch 2020: Biomedical sector

Subject

Top 20 biomedical companies by revenue 2023

Taiwan business watch 2023: Biomedical sector by revenue

Taiwan biomedical sector by revenue 2013-2023

A few years after launch, Taiwan’s homegrown drugs striving for global expansion

Net income of biomedical companies dwindled: H1, 2023

Top 20 biomedical companies by EPS: H1, 2023

Taiwan business watch H1, 2023: Biomedical sector by revenue

Salary 2022: Non-managerial employees in Taiwan’s biomedical sector

Taiwan business watch Q1, 2023: Biomedical sector

Taiwan business watch 2022: Biomedical company profitability

Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment

Taiwan Business Watch H1, 2022: Biomedical Sector

Salary 2021: Non-Managerial Employees in Taiwan’s Biomedical Sector

Taiwan business watch Q1, 2022: Biomedical sector

Taiwan business watch 2021: Biomedical company profitability

Covid-19: FDA authorised and approved drugs and non-vaccine biological products

Taiwan business watch 2021: Biomedical top 20

Taiwan business watch 2021: Biomedical IPOs fueled by 24 new comers

Taiwan business watch Q1 to Q3, 2021: Biomedical sector

Covid-19 New Drugs Race: Overview of Global R&D Progress

Taiwan-Developed Drugs in Global Markets

Taiwan business watch H1, 2021: top performing biomedical companies

Taiwan business watch H1, 2021: Biomedical sector

Race for COVID-19 Vaccine: Global Rollout and Production by Country

Industry salary 2020: Biopharmaceutical non-managerial employees

Taiwan business Watch 2020: Biomedical Photonics

Taiwan business watch Q1, 2021: Biomedical sector

Taiwan business watch 2020: Biomedical sector

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：16F.-1, No.3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978